Edges in Network
| Network | GSE18864_egf1520 - GSE18864 - SiGN-BN HC+Bootstrap |
| Network Description | Tumor expression data from neoadjuvant trial of cisplatin monotherapy in triple negative breast cancer patients |
| Node | HLA-DOA |
| Upstream (Parents) |
|---|
| (<<) ARHGAP25 → HLA-DOA |
| (<<) BCL2A1 → HLA-DOA |
| (<<) CHST11 → HLA-DOA |
| (<<) GPNMB → HLA-DOA |
| (<<) INPP5D → HLA-DOA |
| (<<) LPXN → HLA-DOA |
| (<<) PTGER4 → HLA-DOA |
| (<<) RHOF → HLA-DOA |
| (<<) ZBED2 → HLA-DOA |
| Downstream (Children) |
|---|
| HLA-DOA → ARL4C (>>) |
| HLA-DOA → CCND2 (>>) |
| HLA-DOA → CD274 (>>) |
| HLA-DOA → CSTA (>>) |
| HLA-DOA → CYP1B1 (>>) |
| HLA-DOA → CYP4F2 (>>) |
| HLA-DOA → EMILIN2 (>>) |
| HLA-DOA → GBP2 (>>) |
| HLA-DOA → HLA-A (>>) |
| HLA-DOA → HLA-F (>>) |
| HLA-DOA → IL18 (>>) |
| HLA-DOA → IRF1 (>>) |
| HLA-DOA → ITGB7 (>>) |
| HLA-DOA → KIAA1949 (>>) |
| HLA-DOA → LCP1 (>>) |
| HLA-DOA → NET1 (>>) |
| HLA-DOA → NFKBIE (>>) |
| HLA-DOA → PIK3CD (>>) |
| HLA-DOA → PIK3R5 (>>) |
| HLA-DOA → PITPNC1 (>>) |
| HLA-DOA → PLAUR (>>) |
| HLA-DOA → PLCD4 (>>) |
| HLA-DOA → PRKCB (>>) |
| HLA-DOA → PRKCQ (>>) |
| HLA-DOA → PTAFR (>>) |
| HLA-DOA → RAC2 (>>) |
| HLA-DOA → RASSF5 (>>) |
| HLA-DOA → STAT1 (>>) |
| HLA-DOA → STAT4 (>>) |
| HLA-DOA → STAT5A (>>) |
| HLA-DOA → STK17B (>>) |
| HLA-DOA → SYK (>>) |
| HLA-DOA → TMCC3 (>>) |
